Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma

Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma

Glioblastoma is an incurable cancer with a 5-year survival chance of less than 5%. Chemotherapy is a therapeutic approach to treating the disease; however, due to the presence of the blood–brain barrier (BBB), the probability of success is low. To overcome this issue, nanoparticles are promising car...

Full description

Bibliographic Details
Main Authors: Mohsen Ghaferi, Aun Raza, Maedeh Koohi, Warda Zahra, Azim Akbarzadeh, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceutics
Subjects:
glioblastoma
PEGylated liposome
nanoparticles
nanotechnology
Online Access:https://www.mdpi.com/1999-4923/14/10/2183

Similar Items

Similar Items